Page 5 - Crown Bioscience News Today

Animal Model Market is projected to reach US$ 2.4 Bn by 2028, registering a healthy CAGR of 6.6% from 2022 to 2028 | FMI

/PRNewswire/ -- Crown Bioscience, Inc and ERS Genomics Limited (ERS) have signed a global license agreement for access to the foundational CRISPR/Cas9 patent...

 SAN DIEGO & DUBLIN--(BUSINESS WIRE)--Crown Bioscience, Inc, a JSR Life Sciences Company, and ERS Genomics Limited (‘ERS’) have signed a global license agreement for access to the foundational CRISPR/Cas9 patent portfolio held by ERS, which provides the company full license to operate globally using CRISPR/Cas9 for...

/PRNewswire/ -- The "Laboratory Animal Models, 3D Cultures and Organoids: Global Markets" report has been added to ResearchAndMarkets.coms offering. The...

Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) -- The "Laboratory Animal Models, 3D Cultures and Organoids: Global Markets" report has been added to ...

Global Preclinical Oncology Models market will be valued at US$ 1.02 Billion in 2021. It is expected to reach US$ 2.46 Billion by 2030

SAN FRANCISCO, Sept. 13, 2022 /PRNewswire/ -- The global preclinical CRO market size is expected to reach USD 9.67 billion by 2030, expanding at a CAGR of 7.9%, according to a new report by

The global Animal Model Market is estimated to be valued at US$ 1.7 Bn in 2022, and is projected to reach US$ 2.4 Bn by 2028, registering a healthy CAGR of 6.6% from 2022 to 2028.According to a recently compiled study by Future Market Insights, the global Animal Model Market will reflect an impressive CAGR through t...

/PRNewswire/ -- According to Coherent Market Insights, the global recombinant protein market is estimated to be valued at US$ 494.7 million in 2022 and is...

/PRNewswire/ -- According to Coherent Market Insights, the global recombinant protein market is estimated to be valued at US$ 494.7 million in 2022 and is...